Table 1.
Clinicopathological characteristics of the patients.
| N | 212 | |
|---|---|---|
| Age | Median (range) | 60 (33–96) |
| Tumor size (cm) | ≤2 | 168 |
| >2 | 44 | |
| Lymph node metastasis | Negative | 178 |
| Positive | 34 | |
| Histological grade | 1/2 | 184 |
| 3 | 28 | |
| ER | Positive | 212 |
| Negative | 0 | |
| PgR | Positive | 177 |
| Negative | 35 | |
| HER2 | Positive | 26 |
| Negative | 186 | |
| Histology | IDC | 174 |
| ILC | 17 | |
| Other | 21 | |
| Prognosis | No recurrence | 199 |
| Recurrence | 13 |
ER—estrogen receptor, HER2—human epidermal growth factor receptor 2, IDC—invasive ductal carcinoma, ILC—invasive lobular carcinoma, and PgR—progesterone receptor.